ReviewCardiology research and practice2026
Ionic Disorders in Persistent Atrial Fibrillation: Therapeutic Targeting by Plant-Derived Bioactive Compounds.
Review in Cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistent atrial fibrillation (AF) is associated with distinct ion channel abnormalities and their regulatory mechanisms. This review explores the potential of plant-derived bioactive compounds to correct these dysfunctions. As a prevalent cardiac arrhythmia, AF involves a complex pathogenesis featuring dysregulated activity in potassium, sodium, and calcium channels. Such ionic disturbances foster electrophysiological instability in cardiomyocytes, which contributes to AF initiation and sustenance. Plant-based compounds have attracted considerable attention for their multitargeted actions, low toxicity, and biocompatibility. Emerging evidence indicates that specific phytochemicals can modulate ion channel function and improve myocardial electrical stability, offering potential avenues for AF therapy. However, the precise mechanisms and clinical translational potential of these compounds require further elucidation. By systematically synthesizing current knowledge, this review assesses the value of plant-derived compounds in rectifying ionic imbalances, with the aim of informing the development of novel antiarrhythmic therapies and future research directions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.